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An  active  factor  in  streptococci  which  precipitated  various  mammalian 
plasmas and human and bovine fibrinogens was previously described (1). This 
fibrinogen-precipitating  factor  (FPF)  was  present  in  crude  acid  extracts  of 
several strains of Group A streptococci. The identity of FPF and streptococcal 
M  protein was suggested by: (a) absorption of M protein extracts with fibrino- 
gen  resulted  in  loss  of  precipitation  with  homologous  anti-M  antisera;  (b) 
absorption of M  extracts with homologous anti-M antisera resulted in loss of 
precipitation with fibrinogen; and  (c) treatment of M  extracts with pepsin or 
trypsin resulted in loss of precipitation with both anti-M antiserum and fibrino- 
gen. 
The present report describes experiments confirming the identity of FPF and 
M  protein. Precipitates were prepared by reaction of human fibrinogen with a 
partially purified  preparation  of  streptococcal  M  protein  known  to  contain 
FPF. Immunization of rabbits with washed precipitates resulted in bactericidal, 
mouse  protective,  and  "long-chain"  antibodies  directed  against  homologous 
streptococci,  lmmunoelectrophoretic  analysis  of sera  from these  rabbits  was 
carried out to determine the presence of other plasma proteins in M  fibrinogen 
(M fib.) precipitates. Finally, a rational stoichiometry of the reaction between 
M  protein and fibrinogen was determined with radioactively labeled reactants. 
Materials and Methods 
Streptococd.--Two strains of Type 1 streptococci were used. Strain T 1/155/4 t was stored 
in the lyophili~.ed  state, cultured as needed in Todd-Hewitt broth, and serially passed through 
mice to enhance or maintain virulence. The LDto of T 1/155/4 was between five  and ten or- 
ganisms and only occasional mouse  passage was required to maintain this level; this strain was 
employed in bactericidal, mouse protection, and "long-chain" tests for type-specific  antibody. 
Strain T 1/2788 was obtained as phenolized bacterial cells,  2  which were washed five times in 
saline before use. One Type 12 strain, SF42,  x was stored in the lyophilized state and used to 
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test type specifcity of antisera. Virulence was enhanced or maintained by mouse passage when 
necessary. 
Preparation of Streptococcal M  Protein.--Partially  purified M  protein was prepared from 
both strains of Type 1 streptococci by the method of Lancefield and Perlmann (2). Boundary 
electrophoresis of these preparations at pH 8.6 revealed a single peak with sufficient boundary 
spreading to suggest some heterogeneity. No attempts at further purification were made. 
Preparation of Fibrinogen.--Human fibrinogen (lot 18)  8 was purified by the method of Laki 
(3); purified material contained 93 per cent clottable protein and was used in 0.15 M NaC1 
buffer at pH 7.2. 
Isotopic Labeling of Proteins.--Fibrinogen and streptococcal M protein were lightly labeled 
with 1131 according to the method described by Biozzi, et al. (4). To 40 mg of protein solution 
kept  at  0  to  5 °  C,  0.2  ml of 0.5  per cent  Na2CO3 and 0.8  ml  of  KI3  solution cntaining 
0.6 mc of 113z were added with stirring. The KI~ solution contained 123 mg per cent Is (w/v) 
and 157 per cent KI (w/v). Mter 1 hour, the solution was dialyzed in the cold for 48 hours un- 
til negligible amounts of radioactivity appeared in the dialysate. The amount of iodine bound 
to protein was calculated to be between 1 and 2 atoms per molecule. No change in ability of 
labeled fibrinogen (fib.*)  preparations to clot was observed during the period used. Precipitin 
reactions of labeled M protein (M*) with homologous antiserum remained unimpaired. Radio- 
activity was assayed in a well type scintillation counter. 
Protein Determination.--Concentrations  of protein solutions were  determined by micro- 
Kjeldahl analyses except for radioactive solutions or precipitates; these were measured by the 
Lowry modification of the Folin-Ciocalteu method using human serum albumin as a standard. 
Details of stoichiometry experiments are described with the results. 
Immunological Techniques.--Precipitin tests were performed with the capillary tube tech- 
nique (5). The detailed method used for indirect bactericidal tests has been described pre- 
viously, (6) and summarized below. A normal human serves as the donor; i.e. donor blood alone 
will not inhibit the growth of the inoculated microorganisms. To 0.05 ml of serum from the ani- 
mal to be tested, 0.3 ml of normal, freshly drawn donor blood is added and 0.1 ml of organisms 
introduced. After rotation for 3 hours, a 0.1 ml sample is plated to determine the number of 
surviving bacteria; in the presence of a  suitable donor and type-speeific, anfi-M antibody, 
there is a reduction in the number of bacteria. Conversely in the absence of type-specific anti- 
body, the inoculum increases by a factor of 32 to 64. Positive and negative control sera were 
used in each test. 
Lengthening of the streptococcal chain while growing in anti-M antibody has been described 
by Stollerman and Ekstedt (7). This phenomenon is sensitive to relatively small amounts of 
type-specific antibody. Details of the method have been described previously (8). Briefly, an 
inocuhim of Type 1 organisms is placed in serum to be tested for anti-M antibody. After 3.5 
hours incubation at 37°C, thirty chains are counted, the mean chain length and standard devia- 
tion calculated and compared with mean chain length of streptococci grown in normal rabbit 
serum. The procedures used in mouse protection tests are described with the experiments. 
Immunodectrophoresis.--A  modification of  Scheidegger's technique  (9)  for  agar  gel  im- 
munoelectrophoresis was employed. After washing in normal saline, the slides were dried and 
stained with amidoblack 10B by the method of Uriel and Scheidegger (10). 
Experimental A nlmals.--New Zealand white, male rabbits weighing between 2 and 3 kg were 
used for all immunizations. 
RESU'LTS 
Production  o/Type-Specific Antibodies  by Immunization with M  Fibrinogen 
Precipitates.--To  50 mg of purified fibrinogen dissolved in  10 ml of buffered 
s Obtained from E. R. Squibb & Sons, New York,  New York through the courtesy of the 
American Red Cross. Fm~D S.  KAWrOR  851 
saline was added 3.0 ml of a  1 per cent solution of M  protein. After stirring, the 
mixture was allowed to react at 4°C for 18 hours and the resulting precipitate 
washed five times with 40 ml of buffer. The precipitate was then resuspended 
in  saline  so  that  the  suspension  contained  4  mg/ml  of protein  by Kjeldahl 
analysis.  The  saline  suspension  was  then  emulsified  in  complete  Freund's 
adjuvant (Difco Laboratories, Inc., Detroit) and 0.5 ml of the emulsion injected 
into four sites in each of 2 rabbits. The supernatant fluid from the final wash of 
TABLE I 
Indirect Bactericidal  Tests with Sera from Rabbits Immunized with M-Fibrinogen 
Precipilates and Final Wash of Precipitates 
Test mixture  No. of colonies  of Type 1 
streptococci 
Antigen used in 
immunization  Inoculum, after 3 hours' 
growth in test mixture 
M-fibrinogen 
predpitates 
Final wash of 
M-fibrinogen 
precipitate 
None 
Serum 
Rabbit 1 
"  1 absorbed$ 
"  2 
"  2  " 
Rabbit 3 
"  3 absorbed~ 
"  4 
"  4  " 
Normal rabbit 
"  "  absorbed:~ 
Whole blood 
Normal human 
¢c  gg 
Normal human 
¢c  cc 
Normal human 
500  174  42  16 
~o*  ~o  325C 195 
522  77  4 
oo  ~  275C  4S 
618  154  C 
¢o  oo  2650  6~ 
*o  0o  225{  9~ 
oo  330(  90 
oo  ~o  2100  76 
oo  oo  3600  87q 
oo  ~  2500 101q 
* Indicates innumberable colonies. 
:~ Rabbit sera absorbed with 50 #g increments  of human fibrinogen until  no more pre- 
cipitate.  Equal fibrinogen increments  added  to normal rabbit  serum  and  to serum  from 
rabbits  immunized with final wash of M-fibrinogen precipitate. 
the precipitate  was concentrated by lyophilization to 4  ml and then dialyzed 
vs. normal saline.  After dialysis,  2 ml of the final wash fluid was emulsified in 
complete Freund's adjuvant and 0.5 ml of the emulsion injected into four sites 
of each of 2 rabbits. Two weeks later, all rabbits were given 0.2 ml intradermal 
injections of their respective antigens at four sites. Animals were bled 2 and 4 
weeks after beginning of immunization. Serum was separated and tested for the 
presence of type-specific antibodies. 
As shown in table I, none of the sera proved capable of imparting bactericidal 
properties  to  normal  human  blood.  However,  capillary precipitin  tests  with 
Type 1 M  protein,  0.1 mg/ml, revealed moderate precipitates  in serum  1 and 
2.  Precipitins  for human  fibrinogen  were  also present  in  these  sera.  Normal 852  FIBRINOGEN  PRECIPITATION.  I 
human blood, used as a  source of polymorphonuclear leukocytes in the bac- 
tericidal  tests  also  contains  fibrinogen;  the  probable  presence  of  immune 
precipitates was therefore investigated as an inhibiting factor in the bactericidal 
tests.  One  ml  aliquots  of serum from rabbits  immunized with  M-fibrinogen 
precipitates was absorbed by serial addition of 50 ~g amounts of dried fibrino- 
gen until no further precipitation was noted. Equal fibrinogen increments were 
added to normal rabbit serum and to serum from rabbits immunized with final 
wash of M-fibrinogen precipitates. The ability of the absorbed sera from rabbits 
immunized with M-fibrinogen precipitates to impart bactericidal properties to 
normal human blood is shown in Table I. Failure of "absorbed" control sera to 
TABLE IX 
Specific Protection of Mice by Sera from Rabbits Immunized with M-Fibrinogen Precipitates 
Group A 
Serum  streptococci  used 
Rabbit  T1/155/4  (Type 1) 
1  SF 42  (Type 12) 
Rabbit  T1/155/4  (Type 1) 
2  SF 42  (Type 12) 
Normal  T1/155/4  (Type 1) 
rabbit  SF 42  (Type 12) 
Culture dilutions 
10-s  10-3  104  10  -~  10-e  10-7  104  10  -9 
Mouse  Mouse  Mouse  Mouse  Mouse  Mo~e  Mouse  Mouse 
No.  No.  No.  No.  No.  No.  No.  No. 
12341234!123412341234123412341234 
1  1  1  l  1SSfi  SSSSSSSSSSS$---- 
2  3  2  2  2  2  2  2  2  2  2  2  S2SS 
1  1  1  1  1  2Sfi  SSSSSSSSSSSS-- 
111  1111121S22SS 
1  1  1  1  1  1  1  1  1  2  1  1  1S  1  1  2  S~  SSSSSSSS~ 
• 1  1  1  1  1  1  1  1  1  1  1  1  2  3S  3  1SS-- 
Numeral indicates day of death;  S indicates survival for 10 days. 
* Indicates dilution not tested. 
produce bacterial effects in the test system rules out the possibility that specific 
antibodies were added with  the absorbing fibrinogen preparation. 
Mouse protection tests were performed with sera from rabbits  1 and 2 ob- 
tained 4 weeks after immunization. Swiss  white mice, weighing 20 to 25 gin, 
were injected with 0.5  ml of serum intraperitoneally on the day before each 
challenge: control mice received normal rabbit serum.  Mice were challenged 
intraperitoneally with 0.5 ral each of previously determined appropriate dilu- 
tions of 4- hour Todd-Hewitt broth cultures of the homologous type and one 
heterologous type of Group A  streptococci. Table II shows that the immune 
serums protected mice against between 100 and 1000 LDs0'S of the virulent Type 
1 streptococci. 
To confirm the presence of M  antibodies in the sera of immunized rabbits, 
growth of virulent Type 1 organisms in these sera was observed with reference FRED  S.  KANTOR  853 
to chain length. The mean chain length and standard deviations obtained from 
the sera of 2 immunized rabbits are shown in Table III. The chain  length of 
streptococci grown in these sera were significantly longer  than in  normal  sera 
(P  <  0.001).  The  results  obtained  with  unabsorbed  sera  parallel  those  in 
the precipitin and bactericidal tests. 
Immunoelectrophoresis  of A ntisera Obtained by Immunization with M-Fibrino- 
gen Precipitates.--To determine if the washed precipitates produced by reaction 
of M  protein and human fibrinogen contained other plasma proteins, the anti- 
sera produced in rabbits by immunization with these precipitates  (vide supra) 
were studied by agar-gel immunoelectrophoresis. 
TABLE III 
Comparison of Chain Length of Streptococcus T1/155/4 Grown in Serum from Normal 
and Immunized Rabbits 
Rabbit serum 
No. 1 
No. 2 
No. 3 
Normal serum~ 
Antigen used in immunization 
M-fibrinogen precipitates 
M-fibrinogen precipitates 
Final wash of M-fibrinogen precipitate 
None 
Chain  length 
Standard 
Mean*  deviation 
15.8  4-8.1 
18.7  +10.2 
4.6  q-1.9 
4.1  4-2.0 
* Mean of 30 chains counted. 
:~ Average of means derived from 9 normal rabbit sera. Each mean calculated on the basis 
of 30 chains counted. 
To the top well of each slide was added normal human serum; normal human 
plasma was placed in the bottom well and a current of 6 ma/slide applied for 2 
hours.  Voltages  varied  from  260  to  210v.  After  electrophoresis,  the  center 
trough was cut into each slide  and filled  with antiserum from rabbits  1 and 2 
respectively. After 24 hours' incubation at room temperature in a moist cham- 
ber, the slides were washed for 24 hours in saline,  dried, and stained with amido- 
black.  Precipitin lines  were never observed in the top portion of the slide,  i.e. 
with  human  serum  as  shown  in  Fig.  1.  Two lines  close  to  each  other  were 
regularly seen in the bottom half of each slide. Both lines failed to develop when 
antisera  absorbed  with  purified  fibrinogen  were  used.  The  contamination  of 
partially  purified  fibrinogen  with  plasminogen  is  well  known,  (11)  and  the 
second precipitin line is believed to represent such contamination. In no instance 
were any of the inmmnoglobulin fractions (IgA, IgM, I,G) observed to produce 
precipitin lines  with these rabbit sera. 
Stoichiometry  of M-Fibrinogen  Reactions.--Experiments  designed  to  deter- 
mine the amount of precipitate produced by varying proportions of M  protein 854  FIBRINOGEN PRECIPITATION. I 
and fibrinogen were performed in a  constant volume of 2.5 ml of 0.01  M phos- 
phate-buffered saline.  M  protein was added to  three  sets of tubes  containing 
FIG. 1.  Immunoelectrophoresis  of human serum  (top well, each slide) and human  plasma, 
(bottom well, each slide) vs.  rabbit antiserum 1 (top trough)  and rabbit antiserum 2 (bottom 
trough). 
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FIG. 2.  Effect of addition of M protein to constant amounts of fibrinogen upon amount of 
protein precipitated. 
0.2  rag/tube,  1.0 mg/tube,  and 5.0 mg/tube  of fibrinogen respectively. Reac- 
tion  mixtures  were  incubated  at  4°C  for  24  to  28  hours.  Tubes  were  then 
centrifuged at 3000 G in the cold, supernates removed, and precipitates washed 
three times with cold buffer. 
The effect of addition of increasing amounts of M  protein to constant amounts 
of fibrinogen upon the amount of precipitate is shown in Fig. 2.  M/fibrinogen Fe.ED s.  r~rrog  855 
ratios in these tubes varied from 1/50 to 50/1. With increasing amounts of M 
protein, the amount of protein precipitated increased to a plateau. Great excess 
of M  protein failed to alter total protein precipitated at each fibrinogen con- 
centration. The results suggested a stoichiometric reaction between M protein 
and fibrinogen wherein precipitation was limited by the concentration of one of 
the reactants,  or a  solubility product of continuously variable reactants.  To 
resolve these possibilities, separate experiments were performed with either M 
protein or fibrinogen lightly labeled with 1  lal. As in the previous experiments, 
increments of M protein were added to constant amounts of fibrinogen (1 mg/ 
tube). In addition to protein assay, the contents of M* or Fib.* in supernates 
and precipitates  were  determined by radioassay.  Total protein  and labeled 
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FIG. 3.  Effect of addition of M protein to a constant amount (1 mg) of fibrinogen upon the 
ratio of reactants in the precipitate. 
protein found in supernates and precipitates were required to be 4-7 per cent 
of expected amounts. 
In Fig. 3,  the solid line indicates the fraction of protein in the precipitate 
which was identified as M  protein and refers to the ordinate on the left; this 
fraction increased with increasing increments of M* protein until a plateau of 
0.08 was reached. When labeled fibrinogen was reacted with unlabeled M pro- 
tein, the fraction of fibrinogen in the precipitate is shown by the dotted line 
which refers to the ordinate on the right; this fraction decreased to a plateau of 
0.9 with addition of increasing amounts of M  protein. Results of both experi- 
ments are consistent with each other and illustrate two points; at low levels of 
M  protein  the precipitate  is  almost all fibrinogen, and a  stable complex is 
reached which contains fibrinogen and M  protein in a  ratio of approximately 856  FIBRINOGEN  PRECIPITATION.  I 
10:1. Amounts of protein precipitate were limited by concentration of reactants 
and no prozones were seen in either M  excess or fibHnogen excess. 
DISCUSSION 
The relationship of M protein to virulence and immunity in Group A strep- 
tococcal infections is well established  (12).  Presence of M  protein upon the 
bacterial cell wall is a deterrent to phagocytosis and is believed to be the major 
mechanism of virulence of these organisms. A preliminary report (1) described 
the presence of fibrinogen precipitating factor in crude acid extracts of Group A 
streptococci which could not be separated from M protein. The work reported 
here confirms the identity of FPF and M  protein by demonstration of type- 
specific  anti-M  antibodies  in  sera  of rabbits  immunized with  M-fibrinogen 
precipitates. Whether the ability of M protein to react with fibrinogen plays a 
role in the resistance of M-containing streptococci to phagocytosis is unknown. 
Evidence against this possibility is the direct observation by Hirsch that human 
polymorphonuclear leucocytes phagocytose virulent streptococci in plasma (13). 
Agglutination of hemolytic streptocci by plasma or fibrinogen was described 
by Tillett and Garner (14). It seems probable that this reaction was due to inter- 
action of M  protein on the bacterial cell surface and fibrinogen. Reduction or 
loss of agglutination was observed with organisms heated to 56°C for 1 hour. 
Although this treatment is not likely to have destroyed M  protein,  some is 
released from the cell wall (15);  this soluble M protein might explain decreased 
agglutination by competition with bound M  protein for available fibrinogen. 
Agglutination of bacteria tends to facilitate phagocytosis, not to impede it, 
which also suggests that the properties of M protein as a determinant of viru- 
lence, and as a fibrinogen-precipitating factor, are unrelated. 
Rabbit antisera prepared by immunization with M-fib. precipitates failed to 
impart bactericidal properties to normal human blood. These sera were shown 
by precipitin analyses to contain anti-M and antifibrinogen antibodies. When 
the  latter  were  removed by absorption  with  fibrinogen,  the  sera  conferred 
excellent bactericidal properties when mixed with normal human blood. Roth- 
bard clearly demonstrated non-specific inhibition of the bactericidal test by 
the presence of antigen-antibody precipitates (16). He established that polymor- 
phonuclear leukocytes became engorged with particulate material and appeared 
unable  to  ingest bacteria.  Mouse protection  tests  were  not blocked  by  the 
presence of antifibrinogen antibodies in the rabbit sera; mouse plasma did not 
precipitate with rabbit anti-human fibrinogen, and in vivo the number of poly- 
morphonuclear leukocytes is not limited as in the bactericidal test. Growth in 
long chains of streptococci was also unimpaired by the presence of antifibrino- 
gen antibodies. In this case antigen was not present. 
Precipitation with human sera by acid extracts of Group A, Type 15 strep- 
tococci  has  been  reported  by Wood  and  Schramm  (17).  The  streptococcal FP~D  s.  EnamOR  857 
factor bore similarities  to M protein, but the authors believed it to be a separate 
substance. Kaplan reported faint precipitation of normal goat 3'-2 globulin by a 
high concentration  (50 mg protein per ml)  of an acid extract prepared from 
Group A  streptococci (18).  The immunoelectrophoretic  data reported above 
demonstrate antibodies to two plasma proteins in the sera of rabbits immunized 
with  M-fibrinogen  precipitates.  No precipitin  reactions  were  observed with 
serum proteins; antiserum absorbed with fibrinogen  failed to precipitate with 
plasma. Clearly, the M protein preparation used in these experiments did not 
react with any serum protein. The plasma protein contaminating fibrinogen is 
thought to be plasminogen. 
Human fibrinogen  is a large molecule (tool wt 330,000 to 400,000)  which is 
precipitated from solution by a variety of non-specifc agents including heparin, 
protamine,  and  tosyl-arginine-methyl-ester  (TAME)  (19-22).  Although  the 
mechanism  of aggregation  of fibrinogen  molecules  by these agents or in the 
clotting  process is  complicated  and  unclear,  alteration  of hydrogen  bounds 
appear necessary (11).  In the course of conversion of fibrinogen  to fibrin,  at 
least two polypeptides, A and B, are enzymatically split off. Reaction with M 
protein does not result in release  of these polypeptides (1). Acid-extracted M 
protein has a molecular weight of approximately 40,000 and a pK of 5.3 (22, 2). 
This isoelectric  point is comparable to that of many serum proteins; it seems 
unlikely therefore that fibrinogen  precipitation is due only to extremes of pK 
exhibited by M protein. 
With  increasing  addition  of M  protein  in  fibrinogen  solution,  a  constant 
amount of precipitate is reached, limited in amount by the starting concentra- 
tion of fibrinogen  and constant in M-fibrinogen  proportion of approximately 
1:10.  The  molar  ratio  of  reactants  is  therefore  close  to  1.0. Although  the 
mechanism of fibrinogen  precipitation by M protein is unknown, alteration of 
surface charge on the fibrinogen molecule permitting aggregation is most likely. 
Extraction  of M  protein from M-fib. precipitates by high  ionic strength  salt 
solutions has not proven successful thus far. 
The biological  signifcance of a reaction between bacterial antigen and host 
plasma protein in a setting of clinical infection is unknown at present. Evidence 
indicating that M protein forms intravascular complexes with fibrinogen which 
lead  to  structural  and  functional  renal  lesions  in  experimental  animals  is 
presented in the paper that follows. 
SIYMMARY 
Evidence  confirming  the  identity  of  fibrinogen-precipitating  factor  and 
streptococcal M protein is provided by the demonstration of bactericidal, mouse 
protective, and long chain-producing antibodies in the sera of rabbits immu- 
nized  with  washed M-fibrinogen precipitates.  Two precipitin  lines  were ob- 
served in immunoelectrophoresis of human plasma vs. rabbit anti-M-fibrinogen 858  FIBRINOGEN PRECIPITATION.  I 
antiserum; no precipitin reactions were observed between human serum and 
rabbit  anti-M-fibrinogen  antiserum.  The  reaction  between  M  protein  and 
fibrinogen was  stoichiometric; a  constant  equimolar  ratio  of  reactants  was 
observed in precipitates formed with a wide range of M protein concentrations. 
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